{"id":"ketanests","safety":{"commonSideEffects":[{"rate":null,"effect":"Emergence reactions (dissociative phenomena)"},{"rate":null,"effect":"Increased heart rate and blood pressure"},{"rate":null,"effect":"Dizziness or vertigo"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Transient visual disturbances"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ketanest®S (ketamine S-enantiomer) is an NMDA receptor antagonist that produces dissociative anesthesia by interrupting sensory input to the cerebral cortex while maintaining airway reflexes and respiratory drive. The S-enantiomer formulation offers improved pharmacokinetics and potentially faster recovery compared to racemic ketamine, making it suitable for induction and maintenance of anesthesia in surgical and procedural settings.","oneSentence":"Ketanest®S is a rapid-acting anesthetic that blocks NMDA receptors in the central nervous system to produce dissociative anesthesia and analgesia.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:49:07.002Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Induction and maintenance of general anesthesia"},{"name":"Procedural sedation and analgesia"}]},"trialDetails":[{"nctId":"NCT06092684","phase":"PHASE3","title":"The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery","status":"COMPLETED","sponsor":"Chengdu Brilliant Pharmaceutical Co., Ltd.","startDate":"2023-09-20","conditions":"Laparoscopy, Anesthesia, Intravenous","enrollment":358},{"nctId":"NCT06185426","phase":"EARLY_PHASE1","title":"Histopathological, Biochemical And Electrophysiological Evaluation Of Single Or Combined Use Of Diode Laser/Steroid Treatment On Facial Nerve Injury","status":"UNKNOWN","sponsor":"Recep Tayyip Erdogan University","startDate":"2021-01-01","conditions":"Nerve Injury, Laser Therapy, Methylprednisolone","enrollment":35},{"nctId":"NCT02717052","phase":"PHASE2","title":"Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2016-05","conditions":"Depression, Ketamine","enrollment":74},{"nctId":"NCT02233452","phase":"PHASE4","title":"Methadone and Ketamine for Neuropathic Pain Treatment","status":"COMPLETED","sponsor":"Universidade Federal de Santa Maria","startDate":"2012-01","conditions":"Neuropathic Pain","enrollment":37}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Esketamine"],"phase":"phase_3","status":"active","brandName":"Ketanest®S","genericName":"Ketanest®S","companyName":"Chengdu Brilliant Pharmaceutical Co., Ltd.","companyId":"chengdu-brilliant-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ketanest®S is a rapid-acting anesthetic that blocks NMDA receptors in the central nervous system to produce dissociative anesthesia and analgesia. Used for Induction and maintenance of general anesthesia, Procedural sedation and analgesia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}